These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21912257)

  • 1. Treatment of chronic graft-versus-host disease in 2011.
    Inamoto Y; Flowers ME
    Curr Opin Hematol; 2011 Nov; 18(6):414-20. PubMed ID: 21912257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
    Couriel D; Hosing C; Saliba R; Shpall EJ; Andelini P; Popat U; Donato M; Champlin R
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):37-40. PubMed ID: 16399600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal Photopheresis for Non-skin GvHD.
    Bittenbring J; Reichrath J
    Anticancer Res; 2016 Mar; 36(3):1395-6. PubMed ID: 26977041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal photopheresis in steroid-refractory acute or chronic graft-versus-host disease: results of a systematic review of prospective studies.
    Abu-Dalle I; Reljic T; Nishihori T; Antar A; Bazarbachi A; Djulbegovic B; Kumar A; Kharfan-Dabaja MA
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1677-86. PubMed ID: 24867779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of extracorporeal photopheresis in chronic graft-versus-host disease.
    Radojcic V; Pletneva MA; Couriel DR
    Transfus Apher Sci; 2015 Apr; 52(2):157-61. PubMed ID: 25716169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
    Weitz M; Strahm B; Meerpohl JJ; Bassler D
    Cochrane Database Syst Rev; 2014 Feb; (2):CD009898. PubMed ID: 24569961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial.
    Kitko CL; Braun T; Couriel DR; Choi SW; Connelly J; Hoffmann S; Goldstein S; Magenau J; Pawarode A; Reddy P; Schuler C; Yanik GA; Ferrara JL; Levine JE
    Biol Blood Marrow Transplant; 2016 May; 22(5):862-8. PubMed ID: 26551636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
    Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Panteliadou AK; Lazaridou A; Vardi A; Constantinou V; Yannaki E; Papalexandri A; Kaloyannidis P; Smias C; Anagnostopoulos A
    J Clin Apher; 2018 Dec; 33(6):654-660. PubMed ID: 30394564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal photopheresis in acute and chronic graft-versus-host disease.
    Greinix HT; Worel N; Just U; Knobler R
    Transfus Apher Sci; 2014 Jun; 50(3):349-57. PubMed ID: 24780392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute graft-versus-host disease: are we close to bringing the bench to the bedside?
    Sung AD; Chao NJ
    Best Pract Res Clin Haematol; 2013 Sep; 26(3):285-92. PubMed ID: 24309532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal photopheresis as first-line strategy in the treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: A single-center experience.
    Sestili S; Eder S; Belhocine R; Dulery R; Battipaglia G; Brissot E; Mediavilla C; Banet A; van de Wyngaert Z; Paviglianiti A; Ledraa T; Bonin A; Mohty M; Malard F
    Cytotherapy; 2020 Aug; 22(8):445-449. PubMed ID: 32434750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Graft-versus-host disease (GvHD) - an update. Part 2: prognosis and therapy of GvHD].
    Travnik R; Beckers M; Wolff D; Holler E; Landthaler M; Karrer S
    Hautarzt; 2011 Mar; 62(3):229-37; quiz 238-9. PubMed ID: 21308356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute graft-versus-host disease: new treatment strategies.
    Paczesny S; Choi SW; Ferrara JL
    Curr Opin Hematol; 2009 Nov; 16(6):427-36. PubMed ID: 19812490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical and cellular strategies in prophylaxis and treatment of graft-versus-host disease.
    Wolff D; Steiner B; Hildebrandt G; Edinger M; Holler E
    Curr Pharm Des; 2009; 15(17):1974-97. PubMed ID: 19519437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of graft versus host disease (GVHD) by photopheresis?
    Schooneman F; Claise C
    Transfus Sci; 1996 Dec; 17(4):527-36. PubMed ID: 10168550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
    Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R
    Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic graft-versus-host disease: clinical manifestation and therapy.
    Ratanatharathorn V; Ayash L; Lazarus HM; Fu J; Uberti JP
    Bone Marrow Transplant; 2001 Jul; 28(2):121-9. PubMed ID: 11509929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal photopheresis for GVHD prophylaxis after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation: a prospective multicenter phase 2 study.
    Michallet M; Sobh M; Garban F; Bulabois CE; Yakoub-Agha I; Coiteux V; Dulery R; Rohrlich PS; Legrand F; Clement L; Praire A; Detrait M; Barraco F; Nicolini FE; Hequet O
    Leuk Lymphoma; 2018 Feb; 59(2):372-380. PubMed ID: 28587506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal photopheresis in graft-versus-host disease.
    Carcagnì MR; De Aloe G; D'Ascenzo G; Rubegni P; Fimiani M
    J Dtsch Dermatol Ges; 2008 Jun; 6(6):451-7. PubMed ID: 18177413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of extracorporeal photopheresis in pediatric patients with graft-versus-host disease after hematopoietic stem cell transplantation.
    Winther-Jørgensen S; Nygaard M; Heilmann C; Ifversen M; Sørensen K; Müller K; Masmas T
    Pediatr Transplant; 2019 Jun; 23(4):e13416. PubMed ID: 30973668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.